In this study, we identified a recurrent, and therapeutically relevant inter-chromosomal fusion, UBE3C-LRP5, through transcriptome sequencing and RT-PCR-based analysis of HNSCC primary tumor samples. The gene discussed is LRP5; the disease is head and neck squamous cell carcinoma.